314 related articles for article (PubMed ID: 34974065)
21. c-Rel Is Required for IL-33-Dependent Activation of ILC2s.
Zaini A; Fulford TS; Grumont RJ; Runting J; Rodrigues G; Ng J; Gerondakis S; Zaph C; Scheer S
Front Immunol; 2021; 12():667922. PubMed ID: 34194431
[TBL] [Abstract][Full Text] [Related]
22. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
[TBL] [Abstract][Full Text] [Related]
23. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
[TBL] [Abstract][Full Text] [Related]
24. Bilirubin represents a negative regulator of ILC2 in allergic airway inflammation.
He J; Jiang G; Li X; Xiao Q; Chen Y; Xu H; Liu G; Lei A; Zhou P; Shi K; Yang Q; Zhao M; Yao Z; Zhou J
Mucosal Immunol; 2022 Feb; 15(2):314-326. PubMed ID: 34686839
[TBL] [Abstract][Full Text] [Related]
25. SLAM-family receptors promote resolution of ILC2-mediated inflammation.
Wang Y; Quan Y; He J; Chen S; Dong Z
Nat Commun; 2024 Jun; 15(1):5056. PubMed ID: 38871792
[TBL] [Abstract][Full Text] [Related]
26. Epigenome analysis links gene regulatory elements in group 2 innate lymphocytes to asthma susceptibility.
Stadhouders R; Li BWS; de Bruijn MJW; Gomez A; Rao TN; Fehling HJ; van IJcken WFJ; Lim AI; Di Santo JP; Graf T; Hendriks RW
J Allergy Clin Immunol; 2018 Dec; 142(6):1793-1807. PubMed ID: 29486229
[TBL] [Abstract][Full Text] [Related]
27. Regnase-1 degradation is crucial for IL-33- and IL-25-mediated ILC2 activation.
Matsushita K; Tanaka H; Yasuda K; Adachi T; Fukuoka A; Akasaki S; Koida A; Kuroda E; Akira S; Yoshimoto T
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31990689
[TBL] [Abstract][Full Text] [Related]
28. Mediation of the JNC/ILC2 pathway in DBP-exacerbated allergic asthma: A molecular toxicological study on neuroimmune positive feedback mechanism.
Xie X; Li Y; Yan B; Peng Q; Yao R; Deng Q; Li J; Wu Y; Chen S; Yang X; Ma P
J Hazard Mater; 2024 Mar; 465():133360. PubMed ID: 38157815
[TBL] [Abstract][Full Text] [Related]
29. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
30. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
31. E-Protein Inhibition in ILC2 Development Shapes the Function of Mature ILC2s during Allergic Airway Inflammation.
Barshad G; Webb LM; Ting HA; Oyesola OO; Onyekwere OG; Lewis JJ; Rice EJ; Matheson MK; Sun XH; von Moltke J; Danko CG; Tait Wojno ED
J Immunol; 2022 Mar; 208(5):1007-1020. PubMed ID: 35181641
[TBL] [Abstract][Full Text] [Related]
32. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
[TBL] [Abstract][Full Text] [Related]
33. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
34. Cell-surface molecule-mediated cell-cell interactions in the regulation of ILC2-driven allergic inflammation.
Lei A; Zhou J
Cell Mol Life Sci; 2019 Nov; 76(22):4503-4510. PubMed ID: 31312878
[TBL] [Abstract][Full Text] [Related]
35. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
[TBL] [Abstract][Full Text] [Related]
36. Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation.
Huang Y; Li X; Zhu L; Huang C; Chen W; Ling Z; Zhu S; Feng X; Yi C; Gu W; Yan C; Wang J; Ma L; Su X; Dai R; Shi G; Sun B; Zhang Y
Allergy; 2022 Jul; 77(7):2104-2120. PubMed ID: 34995358
[TBL] [Abstract][Full Text] [Related]
37. ICAM-1 controls development and function of ILC2.
Lei AH; Xiao Q; Liu GY; Shi K; Yang Q; Li X; Liu YF; Wang HK; Cai WP; Guan YJ; Gabrilovich DI; Zhou J
J Exp Med; 2018 Aug; 215(8):2157-2174. PubMed ID: 30049704
[TBL] [Abstract][Full Text] [Related]
38. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia.
Liu B; Lee JB; Chen CY; Hershey GK; Wang YH
J Immunol; 2015 Apr; 194(8):3583-93. PubMed ID: 25780046
[TBL] [Abstract][Full Text] [Related]
39. Salidroside suppresses group 2 innate lymphoid cell-mediated allergic airway inflammation by targeting IL-33/ST2 axis.
Cai H; Wang J; Mo Y; Ye L; Zhu G; Song X; Zhu M; Xue X; Yang C; Jin M
Int Immunopharmacol; 2020 Apr; 81():106243. PubMed ID: 32070919
[TBL] [Abstract][Full Text] [Related]
40. Acrylamide, an air pollutant, enhances allergen-induced eosinophilic lung inflammation via group 2 innate lymphoid cells.
Su HH; Cheng CM; Yang YN; Chang YW; Li CY; Wu ST; Lin CC; Wu HE; Suen JL
Mucosal Immunol; 2024 Feb; 17(1):13-24. PubMed ID: 37805143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
